Vectibix superior to bevacizumab in Japanese patients with wild-type RAS mCRC

COTA and Sanofi collaborate to accelerate cancer trials using real-world data and AI

COTA, a leader in real-world data and analytics for oncology, is entering a collaboration with Sanofi to use RWD and artificial intelligence to increase the speed of oncology trials, including for multiple myeloma.

April 19, 2024

Vol.50 No.16

Clinical Roundup

One in five people with cancer participate in medical research studies, Fred Hutchinson study shows

Researchers from Fred Hutchinson Cancer Center, the American Cancer Society Cancer Action Network, and peer institutions released findings in the Journal of Clinical Oncology showing that when all types of cancer research studies are considered, at least one in five people with cancer, or 21.9%, participate in some form of clinical research.

April 05, 2024

Vol.50 No.14

Clinical Roundup

Phase II study of personalized cancer vaccine in CRC shows positive preliminary PFS and long-term ctDNA data

The ongoing, signal-seeking phase II portion of the phase II/III study evaluating Granite, a personalized neoantigen cancer vaccine, in front-line metastatic microsatellite stable colorectal cancer, produced positive preliminary data.

April 05, 2024

Vol.50 No.14

Regulatory News

Exercising new powers, FDA issues Complete Response Letters based on insufficient enrollment in confirmatory trials

FDA issued Complete Response Letters for the Biologics License Application for odronextamab in relapsed/refractory follicular lymphoma and in R/R diffuse large B-cell lymphoma, each after two or more lines of systemic therapy.

Etta Pisano named senior portfolio lead at ARPA-H

Etta D. Pisano was named senior portfolio lead at the Advanced Research Projects Agency for Health.

March 29, 2024

Vol.50 No.13

In Brief

UVA, Southwest Virginia providers partner to boost CRC screening

The Community Health Center of the New River Valley and the University of Virginia Cancer Center partnered to boost southwest Virginia’s colorectal cancer screening rate by mailing at-home test kits to patients.

March 29, 2024

Vol.50 No.13

Vectibix superior to bevacizumab in Japanese patients with wild-type RAS mCRC

YOU MAY BE INTERESTED IN

COTA and Sanofi collaborate to accelerate cancer trials using real-world data and AI

One in five people with cancer participate in medical research studies, Fred Hutchinson study shows

Phase II study of personalized cancer vaccine in CRC shows positive preliminary PFS and long-term ctDNA data

Exercising new powers, FDA issues Complete Response Letters based on insufficient enrollment in confirmatory trials

Etta Pisano named senior portfolio lead at ARPA-H

UVA, Southwest Virginia providers partner to boost CRC screening

Renew today!

Subscriber content

Login